Comparative impact of stirring and shearing in drug dissolution testing with usp paddle and crescent-shaped spindles

Dissolution Technologies

Volumn 13, Issue 1, 2006, Pages 25-30

  Qureshi, Saeed A ^a  

^a Banting Research Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DILTIAZEM;

ARTICLE; CRESCENT SHAPED SPINDLE; DRUG CAPSULE; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; EXTENDED DRUG RELEASE; GENERAL DEVICE; PHYSICAL PARAMETERS; SHEARING; STIRRING; USP PADDLE APPARATUS;

EID: 84962074763     PISSN: 1521298X     EISSN: None     Source Type: Journal    
DOI: 10.14227/DT130106P25     Document Type: Article

References (18)

1. General Chapters <711> and <724>, United States Pharmacopeia 28, The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2005, pp 2412-2422.
2. Guidance for Industry: Dissolution Testing of Immediate Release Solid Oral Dosage Forms. U. S. Department of Health and Human Services, Food and Drug Administration, U. S. Government Printing Office: Washington, DC, 1997, http: //www. fda. gov/cder/ guidance/1713bp1. pdf.
3. Guidance for Industry: Extended Release Oral Dosage Forms: Development, Evaluation, and Application of In Vitro/In Vivo Correlations. U. S. Department of Health and Human Services, Food and Drug Administration, U. S. Government Printing Office: Washington, DC, 1997, http: //www. fda. gov/cder/guidance/1306fnl. pdf.
4. McCarthy, L. G.; Kosiol, C.; Healy, A. M.; Bradley, G.; Sexton, J. C.; Corngan, O. I. Simulating the Hydrodynamic Conditions in the United States Pharmacopeia Paddle Dissolution Apparatus. AAPS PharmSciTech 2003, 4, 172-187.
5. McCarthy, L. G.; Bradley, G.; Sexton, J. C.; Corrigan, O. I.; Healy, A. M. Computational Fluid Dynamics Modeling of the Paddle Dissolution Apparatus: Agitation Rate, Mixing Patterns, and Fluid Velocities. AAPS PharmSciTech. 2004, 5, 1-10.
6. Qureshi, S. A.; McGilveray, I. J. A Critical Assessment of the USP Dissolution Apparatus Suitability Test Criteria. Drug Develop. Ind. Pharm. 1995, 21, 905-992.
7. Qureshi, S. A.; McGilveray, I. J. Assessment of Pharmaceutical Quality of Furosemide Tablets From Multinational Markets. Drug Devel. Ind. Pharm. 1998, 24, 995-1005.
8. Qureshi, S. A.; McGilveray, I. J. Typical Variability in Drug Dissolution Testing: Study with USP and FDA Calibrator Tablets and a Marketed Drug (Glibenclamide) Product. Eur. J. Pharm. Sci. 1999, 7, 249-258.
9. Muzzio, F. J.; Kukura, J.; Baxter, J. L. Hydrodynamicsinduced Variability in the USP II Dissolution Test. Int. J. Pharm. 2005, 292, 17-28.
10. Meyer, M. C.; Straughn, A. B.; Mhatre, R. M.; Shah, V. P.; Williams, R. L.; Lesko, L. J. Lack of In Vivo/In Vitro Correlations for 50 mg and 250 mg Primidone Tablets. Pharm. Res. 1998, 15, 1085-1089.
11. Repta, A. J. Dissolution Specifications for Drug Products. AAPS Pharmsci. 1999, Suppl., 2531.
12. Qureshi, S. A. Choice of Rotation Speed (rpm) for Biorelevant Drug Dissolution Testing Using a Crescentshape Spindle. Eur. J. Pharm. Sci. 2004, 23, 271-275.
13. Qureshi, S. A. Improved Drug Dissolution and Product Characterization Using the Crescent-shaped Spindle. J. Pharm. Pharmacol. 2004, 56, 1135-1141.
14. Qureshi, S. A.; Shabnam, J. Applications of a New Device (Spindle) for Improved Characterization of Drug Release (Dissolution) of Pharmaceutical Products. Eur. J. Pharm. Sci. 2003, 19, 291-297.
15. Qureshi, S. A. A New Crescent-shaped Spindle for Drug Dissolution Testing-but Why a New Spindle? Dissolution Technologies 2004, 11, 13-18.
16. Monograph: Diltiazem Hydrochloride Tablets, United States Pharmacopeia 28; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2005; pp 655-658.
17. Morihara, M.; Aoyagi, N.; Kaniwa, N.; Katori, N.; Kojim, S. Hydrodynamic Flows Around Tablets in Different Pharmacopeial Dissolution Tests. Drug Develop. Ind. Pharm. 2002, 28, 655-662.
18. Leeson, L. J.; Mayersohn, M. Letter to the Editor. Dissolution Technologies 2005, 12, 24-33.